Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Corrigendum. CD4+ T cell-independent DNA vaccination against opportunistic infections.

Zheng M, Ramsay AJ, Robichaux MB, Kliment C, Crowe C, Rapaka RR, Steele C, McAllister F, Shellito JE, Marrero L, Schwarzenberger P, Zhong Q, Kolls JK.

J Clin Invest. 2015 Mar 2;125(3):1364. doi: 10.1172/JCI81228. Epub 2015 Mar 2. No abstract available.

2.

Multicenter phase II study of a combination of cyclosporine a, methotrexate and mycophenolate mofetil for GVHD prophylaxis: results of the Chinese Bone Marrow Transplant Cooperative Group (CBMTCG).

Lai YR, Chen YH, Hu DM, Jiang M, Liu QF, Liu L, Hou J, Schwarzenberger P, Li QC, Zhang ZM, Liu KY, Huang XJ.

J Hematol Oncol. 2014 Aug 21;7:59. doi: 10.1186/s13045-014-0059-3.

3.

Oncofetal antigen/immature laminin receptor protein in pregnancy and cancer.

Barsoum AL, Schwarzenberger PO.

Cell Mol Biol Lett. 2014 Sep;19(3):393-406. doi: 10.2478/s11658-014-0203-7. Epub 2014 Jul 31. Review.

PMID:
25082063
4.

A phase 2 randomized trial of paclitaxel and carboplatin with or without panitumumab for first-line treatment of advanced non-small-cell lung cancer.

Crawford J, Swanson P, Schwarzenberger P, Sandler A, Prager D, Zhang K, Freeman DJ, Johnson CW, Krishnan K, Johnson D.

J Thorac Oncol. 2013 Dec;8(12):1510-8. doi: 10.1097/JTO.0b013e3182a7d1da.

5.

Requirement of TPO/c-mpl for IL-17A-induced granulopoiesis and megakaryopoiesis.

Tan W, Liu B, Barsoum A, Huang W, Kolls JK, Schwarzenberger P.

J Leukoc Biol. 2013 Dec;94(6):1303-8. doi: 10.1189/jlb.1212639. Epub 2013 Aug 29.

6.

CD34+ hematopoietic stem cells support entry and replication of poliovirus: a potential new gene introduction route.

Freistadt M, Eberle KE, Huang W, Schwarzenberger P.

Cancer Gene Ther. 2013 Mar;20(3):201-7. doi: 10.1038/cgt.2013.2. Epub 2013 Feb 8.

PMID:
23392202
7.

Experimental chronic hepatitis B infection of neonatal tree shrews (Tupaia belangeri chinensis): a model to study molecular causes for susceptibility and disease progression to chronic hepatitis in humans.

Wang Q, Schwarzenberger P, Yang F, Zhang J, Su J, Yang C, Cao J, Ou C, Liang L, Shi J, Yang F, Wang D, Wang J, Wang X, Ruan P, Li Y.

Virol J. 2012 Aug 23;9:170. doi: 10.1186/1743-422X-9-170.

8.

Treatment of mesothelioma with gene-modified PA1STK cells and ganciclovir: a phase I study.

Schwarzenberger P, Byrne P, Gaumer R, Norton J, Harrison L, Marrogi A, Kolls JK.

Cancer Gene Ther. 2011 Dec;18(12):906-12. doi: 10.1038/cgt.2011.60. Epub 2011 Sep 9.

PMID:
21904395
9.

Dose escalation of once weekly oral vinorelbine concurrent with weekly split dose hypofractionated chest radiation for palliation of advanced non-small cell lung cancer: a phase I/II study.

Schwarzenberger P, Fariss A, Linares L, Nedzi L, Salazar OM.

Am J Med Sci. 2011 Jun;341(6):454-9. doi: 10.1097/MAJ.0b013e3182127b3f.

PMID:
21613934
10.

IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement.

Liu B, Tan W, Barsoum A, Gu X, Chen K, Huang W, Ramsay A, Kolls JK, Schwarzenberger P.

Exp Hematol. 2010 Oct;38(10):877-884.e1. doi: 10.1016/j.exphem.2010.06.004. Epub 2010 Jun 19.

PMID:
20600582
11.

Targeted agents for chronic myelogenous leukemia: will that be the end of allogeneic bone marrow transplantation for that disease?

Liang Y, Lai Y, Schwarzenberger P, Li Q, Ma J, Luo J, Liu R, Shi L, Zhou J, Peng Z, Yang J, Deng D, Zhou Y.

Biol Blood Marrow Transplant. 2010 Jun;16(6):848-53. doi: 10.1016/j.bbmt.2010.01.016. Epub 2010 Feb 4.

12.

Biochemical characterization of riboflavin carrier protein (RCP) in prostate cancer.

Johnson T, Ouhtit A, Gaur R, Fernando A, Schwarzenberger P, Su J, Ismail MF, El-Sayyad HI, Karande A, Elmageed ZA, Rao P, Raj M.

Front Biosci (Landmark Ed). 2009 Jan 1;14:3634-40.

PMID:
19273299
13.

Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein.

Barsoum AL, Liu B, Rohrer JW, Coggin JH Jr, Tucker JA, Pannell LK, Schwarzenberger PO.

Biomaterials. 2009 Jun;30(17):3091-9. doi: 10.1016/j.biomaterials.2009.02.022. Epub 2009 Mar 6.

PMID:
19268360
14.

Combination of CsA, MTX and low-dose, short-course mycophenolate mofetil for GVHD prophylaxis.

Lai Y, Ma J, Schwarzenberger P, Li W, Cai Z, Zhou J, Peng Z, Yang J, Luo L, Luo J, Deng D, Li Q, Zhou Y, Liang J.

Bone Marrow Transplant. 2009 Jan;43(1):61-7. doi: 10.1038/bmt.2008.265. Epub 2008 Aug 25.

PMID:
18724395
15.

IL-17F/IL-17R interaction stimulates granulopoiesis in mice.

Tan W, Huang W, Gu X, Zhong Q, Liu B, Schwarzenberger P.

Exp Hematol. 2008 Nov;36(11):1417-27. doi: 10.1016/j.exphem.2008.06.003. Epub 2008 Aug 23.

PMID:
18723265
16.

Phase I study of flavopiridol in combination with Paclitaxel and Carboplatin in patients with non-small-cell lung cancer.

George S, Kasimis BS, Cogswell J, Schwarzenberger P, Shapiro GI, Fidias P, Bukowski RM.

Clin Lung Cancer. 2008 May;9(3):160-5. doi: 10.3816/CLC.2008.n.024.

PMID:
18621626
17.

Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.

Ramlau R, Zatloukal P, Jassem J, Schwarzenberger P, Orlov SV, Gottfried M, Pereira JR, Temperley G, Negro-Vilar R, Rahal S, Zhang JK, Negro-Vilar A, Dziewanowska ZE.

J Clin Oncol. 2008 Apr 10;26(11):1886-92. doi: 10.1200/JCO.2007.12.2614.

PMID:
18398154
18.

Phase 2 trial of Allovectin-7 in advanced metastatic melanoma.

Gonzalez R, Hutchins L, Nemunaitis J, Atkins M, Schwarzenberger PO.

Melanoma Res. 2006 Dec;16(6):521-6.

PMID:
17119453
19.

Phase II study of belagenpumatucel-L, a transforming growth factor beta-2 antisense gene-modified allogeneic tumor cell vaccine in non-small-cell lung cancer.

Nemunaitis J, Dillman RO, Schwarzenberger PO, Senzer N, Cunningham C, Cutler J, Tong A, Kumar P, Pappen B, Hamilton C, DeVol E, Maples PB, Liu L, Chamberlin T, Shawler DL, Fakhrai H.

J Clin Oncol. 2006 Oct 10;24(29):4721-30. Epub 2006 Sep 11.

PMID:
16966690
20.

Critical role of IL-17 receptor signaling in acute TNBS-induced colitis.

Zhang Z, Zheng M, Bindas J, Schwarzenberger P, Kolls JK.

Inflamm Bowel Dis. 2006 May;12(5):382-8.

PMID:
16670527
21.

IL-17 receptor knockout mice have enhanced myelotoxicity and impaired hemopoietic recovery following gamma irradiation.

Tan W, Huang W, Zhong Q, Schwarzenberger P.

J Immunol. 2006 May 15;176(10):6186-93.

22.

Interleukin-17A: a T-cell-derived growth factor for murine and human mesenchymal stem cells.

Huang W, La Russa V, Alzoubi A, Schwarzenberger P.

Stem Cells. 2006 Jun;24(6):1512-8. Epub 2006 Mar 2.

23.

CD4+ T cell-independent DNA vaccination against opportunistic infections.

Zheng M, Ramsay AJ, Robichaux MB, Kliment C, Crowe C, Rapaka RR, Steele C, McAllister F, Shellito JE, Marrero L, Schwarzenberger P, Zhong Q, Kolls JK.

J Clin Invest. 2005 Dec;115(12):3536-44. Epub 2005 Nov 23. Erratum in: J Clin Invest. 2015 Mar 2;125(3):1364. Norris, Karen A [Deleted].

24.

Retrovirus molecular conjugates: a versatile and efficient gene transfer vector system for primitive human hematopoietic progenitor cells.

Yang G, Zhong Q, Huang W, Reiser J, Schwarzenberger P.

Cancer Gene Ther. 2006 May;13(5):460-8.

PMID:
16282988
25.

Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3, 9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis.

Koenders MI, Kolls JK, Oppers-Walgreen B, van den Bersselaar L, Joosten LA, Schurr JR, Schwarzenberger P, van den Berg WB, Lubberts E.

Arthritis Rheum. 2005 Oct;52(10):3239-47.

26.

Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis.

Lubberts E, Schwarzenberger P, Huang W, Schurr JR, Peschon JJ, van den Berg WB, Kolls JK.

J Immunol. 2005 Sep 1;175(5):3360-8.

27.

Development of a gene therapy based bone marrow purging system for leukemias.

Huang W, Tan W, Zhong Q, Schwarzenberger P.

Cancer Gene Ther. 2005 Nov;12(11):873-83.

PMID:
15891774
28.

Interleukin-17/interleukin-17 receptor-mediated signaling is important for generation of an optimal polymorphonuclear response against Toxoplasma gondii infection.

Kelly MN, Kolls JK, Happel K, Schwartzman JD, Schwarzenberger P, Combe C, Moretto M, Khan IA.

Infect Immun. 2005 Jan;73(1):617-21.

29.

Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer.

Lilenbaum RC, Chen CS, Chidiac T, Schwarzenberger PO, Thant M, Versola M, Lane SR.

Ann Oncol. 2005 Jan;16(1):97-101.

PMID:
15598945
30.

Dose escalation of docetaxel concomitant with hypofractionated, once weekly chest radiotherapy for non-small-cell lung cancer: a phase I study.

Schwarzenberger P, Theodossiou C, Barron S, Diethelm L, Boyle M, Harrison L, Wynn RB, Salazar OM, Fariss A.

Am J Clin Oncol. 2004 Aug;27(4):395-9.

PMID:
15289734
31.

Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice.

Huang W, Na L, Fidel PL, Schwarzenberger P.

J Infect Dis. 2004 Aug 1;190(3):624-31. Epub 2004 Jun 22.

PMID:
15243941
32.

Replication of an adenoviral vector controlled by the human telomerase reverse transcriptase promoter causes tumor-selective tumor lysis.

Lanson NA Jr, Friedlander PL, Schwarzenberger P, Kolls JK, Wang G.

Cancer Res. 2003 Nov 15;63(22):7936-41.

33.

IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.

Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, van den Berg WB.

J Immunol. 2003 Mar 1;170(5):2655-62.

34.

Retrovirus molecular conjugates.

Zhong Q, Kolls JK, Schwarzenberger P.

Cell Mol Life Sci. 2002 Dec;59(12):2083-7.

PMID:
12568334
35.

Non-Hodgkin's lymphomas.

Theodossiou C, Schwarzenberger P.

Clin Obstet Gynecol. 2002 Sep;45(3):820-9. Review. No abstract available.

PMID:
12370624
36.

Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis.

Schwarzenberger P, Kolls JK.

J Cell Biochem Suppl. 2002;38:88-95. Review.

PMID:
12046855
37.

Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells.

Zhang XY, La Russa VF, Bao L, Kolls J, Schwarzenberger P, Reiser J.

Mol Ther. 2002 May;5(5 Pt 1):555-65.

38.

Overexpression of IL-17 in the knee joint of collagen type II immunized mice promotes collagen arthritis and aggravates joint destruction.

Lubberts E, Joosten LA, van de Loo FA, Schwarzenberger P, Kolls J, van den Berg WB.

Inflamm Res. 2002 Feb;51(2):102-4. No abstract available.

PMID:
11930902
39.

Hematopoietic stem cells.

Schwarzenberger P, Kolls JK, La Russa V.

Cancer Invest. 2002;20(1):124-38. Review. No abstract available.

PMID:
11852995
40.

Marrow stem cells, mesenchymal progenitor cells, and stromal progeny.

La Russa VF, Schwarzenberger P, Miller A, Agrawal K, Kolls J, Weiner R.

Cancer Invest. 2002;20(1):110-23. Review. No abstract available.

PMID:
11852994
41.

Chimerism analysis in sex-mismatched murine transplantation using quantitative real-time PCR.

Byrne P, Huang W, Wallace VM, Shean MK, Zhang Z, Zhong Q, Theodossiou C, Blakesley H, Kolls JK, Schwarzenberger P.

Biotechniques. 2002 Feb;32(2):279-80, 282-4, 286.

PMID:
11848403
42.

Acute alcohol intoxication suppresses the CXC chemokine response during endotoxemia.

Zhang P, Bagby GJ, BoƩ DM, Zhong Q, Schwarzenberger P, Kolls JK, Summer WR, Nelson S.

Alcohol Clin Exp Res. 2002 Jan;26(1):65-73.

PMID:
11821656
43.

Increased granulopoiesis through interleukin-17 and granulocyte colony-stimulating factor in leukocyte adhesion molecule-deficient mice.

Forlow SB, Schurr JR, Kolls JK, Bagby GJ, Schwarzenberger PO, Ley K.

Blood. 2001 Dec 1;98(12):3309-14.

44.

CD4+ T cell-independent vaccination against Pneumocystis carinii in mice.

Zheng M, Shellito JE, Marrero L, Zhong Q, Julian S, Ye P, Wallace V, Schwarzenberger P, Kolls JK.

J Clin Invest. 2001 Nov;108(10):1469-74.

45.

Interleukin-17 and lung host defense against Klebsiella pneumoniae infection.

Ye P, Garvey PB, Zhang P, Nelson S, Bagby G, Summer WR, Schwarzenberger P, Shellito JE, Kolls JK.

Am J Respir Cell Mol Biol. 2001 Sep;25(3):335-40.

PMID:
11588011
46.

Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells.

Zhong Q, Oliver P, Huang W, Good D, La Russa V, Zhang Z, Cork JR, Veith RW, Theodossiou C, Kolls JK, Schwarzenberger P.

J Virol. 2001 Nov;75(21):10393-400.

47.

Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense.

Ye P, Rodriguez FH, Kanaly S, Stocking KL, Schurr J, Schwarzenberger P, Oliver P, Huang W, Zhang P, Zhang J, Shellito JE, Bagby GJ, Nelson S, Charrier K, Peschon JJ, Kolls JK.

J Exp Med. 2001 Aug 20;194(4):519-27.

48.

Il-17 mobilizes peripheral blood stem cells with short- and long-term repopulating ability in mice.

Schwarzenberger P, Huang W, Oliver P, Byrne P, La Russa V, Zhang Z, Kolls JK.

J Immunol. 2001 Aug 15;167(4):2081-6.

49.

IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis.

Lubberts E, Joosten LA, Oppers B, van den Bersselaar L, Coenen-de Roo CJ, Kolls JK, Schwarzenberger P, van de Loo FA, van den Berg WB.

J Immunol. 2001 Jul 15;167(2):1004-13.

50.

Retrovirus molecular conjugates. A novel, high transduction efficiency, potentially safety-improved, gene transfer system.

Zhong Q, Kolls JK, Schwarzenberger P.

J Biol Chem. 2001 Jul 6;276(27):24601-7. Epub 2001 Apr 19.

Supplemental Content

Loading ...
Support Center